| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/15/2009 | US20090018072 High protein supplement |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018065 Plant PR-5 proteins as mammalian therapeutic agents |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090018055 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 01/15/2009 | US20090018053 Formulations for amylin agonist peptides |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017047 Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders |
| 01/15/2009 | US20090017043 Connective tissues growth factor antibodies |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090016984 lanthanum polystyrene sulfonate; gastrointestinal administration |
| 01/15/2009 | US20090016968 Composition and method for prevention and treatment of type i diabetes |
| 01/15/2009 | CA2692539A1 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin |
| 01/15/2009 | CA2692515A1 Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
| 01/15/2009 | CA2682096A1 Klotho beta |
| 01/14/2009 | EP2014679A1 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014678A2 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014652A1 Activating agent for peroxisome proliferator activated receptor |
| 01/14/2009 | EP2014297A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2013204A2 2-aminopyridine analogs as glucokinase activators |
| 01/14/2009 | EP2013188A1 Rosuvastatin zinc salt |
| 01/14/2009 | EP2013165A1 Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit. |
| 01/14/2009 | EP2012817A2 Rapid acting and long acting insulin combination formulations |
| 01/14/2009 | EP2012775A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators |
| 01/14/2009 | EP2012773A2 Drugs and uses |
| 01/14/2009 | EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 01/14/2009 | EP1609858B1 Method for detecting substrates or inhibitors for branched neutral amino acid transporters |
| 01/14/2009 | EP1516620B1 Rifampicin for treating angiogenesis |
| 01/14/2009 | EP1466900B1 2-substituted vitamin d derivatives |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1443898B1 Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells |
| 01/14/2009 | EP1429769B1 New formulations and use thereof |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1183049B1 Modification of biological elements |
| 01/14/2009 | CN101346387A Pyrimido- [4, 5-]-oxazines for use as DGAT inhibitors |
| 01/14/2009 | CN101346356A Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 01/14/2009 | CN101346352A Asymmetric reduction method |
| 01/14/2009 | CN101346139A Long term weight maintenance |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343296A Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 01/14/2009 | CN101342371A Application of LYRM1 gene in preparing medicament for promoting fat cell proliferation |
| 01/14/2009 | CN101342365A Use of novel glucagon-like peptide-1 (GLP-1) analogue |
| 01/14/2009 | CN101342320A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342314A Traditional Chinese medicine for treating cardiovascular disease, preparation method and uses thereof |
| 01/14/2009 | CN101342311A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342310A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342309A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342308A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342307A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342305A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342304A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342303A Pure natural medicament for treating diabetes |
| 01/14/2009 | CN101342257A Medicament for treating hyperlipemia and preparation method thereof |
| 01/14/2009 | CN101342254A Combination of traditional Chinese medicine extract for preventing and treating atherosis, hyperlipemia, and preparation thereof |
| 01/14/2009 | CN101342241A White Chinese olive angelica oil soft capsule and preparation method thereof |
| 01/14/2009 | CN101342222A Medicament composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342221A Medicament composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342213A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342212A Medicament composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342211A Pharmaceutical composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342207A Chinese medicinal composition for treating coronary disease, stenocardia, arrhythmia, hyperlipemia and preparation method thereof |
| 01/14/2009 | CN101342205A Traditional Chinese medicine preparation for decreasing blood fat |
| 01/14/2009 | CN101342197A Novel formulation of shuck active calcium |
| 01/14/2009 | CN101342186A Use of pentacyclic triterpene saponin compound |
| 01/14/2009 | CN101342184A Nutritional composition with health promoting action containing oligosaccharides |
| 01/14/2009 | CN101342164A Bezafibrate controlled release formulation and preparation method thereof |
| 01/14/2009 | CN101342162A Method of inhibiting remnant lipoprotein production |
| 01/14/2009 | CN101342159A Application of bromine phenolic compound in preparing medicament for treating type 2 diabetes or adiposis |
| 01/14/2009 | CN101342146A Preparation method of glimepiride tablet |
| 01/14/2009 | CN101341979A Health beverage and preparation method |
| 01/14/2009 | CN101341972A Food capable of regulating and controlling blood sugar and preparation method thereof |
| 01/14/2009 | CN101341943A Corn high-strength flour, corn slimming noodle and preparing method |
| 01/14/2009 | CN101341920A Mulberry leaf lozenge and preparation method thereof |
| 01/14/2009 | CN101341915A Multifunctional health tea |
| 01/14/2009 | CN101341870A Preparation and uses of Wuyiencin controllable sustained-release nano-microsphere |
| 01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 01/14/2009 | CN100451008C Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/14/2009 | CN100451004C Novel quinoline,Tetrahydroquinazoline,And pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/14/2009 | CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/14/2009 | CN100450552C Vaccine for diabetes in type I, and constructing method |
| 01/14/2009 | CN100450485C 5-HT 1a receptor subtype agonists |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/14/2009 | CN100450476C Electrolyte complementary medical combination for injection |
| 01/14/2009 | CN100450471C Soft capsule of atovastatine salts and prepn. method therefor |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
| 01/13/2009 | US7476740 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476671 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | US7476652 by addition of surfactants such as nonionic surfactants of the (poly)ethoxylated fatty acid type; storage stability to hydrophobic aggregation nuclei for several months under temperature stress |
| 01/13/2009 | US7476404 Osteoporosis; vitamin D; Calcium Citrate Malate; Potassium Citrate; Magnesium; Boron and Vitamin K |
| 01/13/2009 | US7476392 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 01/13/2009 | US7476388 Gastrin, and a second dose of an epithelial growth factor; in vivo islet cell regeneration, preexisting diabetes, islet neogenesis |
| 01/13/2009 | CA2400312C Nutritional intervention composition for enhancing and extending satiety |
| 01/13/2009 | CA2397785C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/13/2009 | CA2310659C Method for accelerating protein digestion rate |